Dicerna Pharmaceuticals, Inc.
METHODS FOR TREATING HEPATITIS B INFECTION
Last updated:
Abstract:
This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
Status:
Application
Type:
Utility
Filling date:
14 Feb 2020
Issue date:
4 Jun 2020